The Neuroprotective Effects of DPP-4 and SGLT2 Inhibitors in Type 2 Diabetes: Possible Mechanism for Halting Cognitive Deterioration

被引：0
|
作者：
Osman, Shams T. [1 ]
Hamdy, Noha A. [1 ]
El Feky, Amr Y. [2 ]
El-Khordagui, Labiba K. [1 ]
El-Yazbi, Ahmed F. [3 ]
机构：
[1] Alexandria Univ, Fac Pharm, Alexandria, Egypt
[2] Alexandria Univ, Fac Med, Alexandria, Egypt
[3] Alexandria Univ, Alexandria, Egypt
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.138010
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
256
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comparison of SGLT2 inhibitors versus DPP-4 inhibitors as combination with metformin in patients with acute myocardial infarction with diabetes
    Lyu, Y.
    Oh, S.
    Kim, J.
    Jeong, M.
    Kim, S.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S474 - S475
  • [22] Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
    Young Sang Lyu
    Seok Oh
    Jin Hwa Kim
    Sang Yong Kim
    Myung Ho Jeong
    Cardiovascular Diabetology, 22
  • [23] Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
    Lyu, Young Sang
    Oh, Seok
    Kim, Jin Hwa
    Kim, Sang Yong
    Jeong, Myung Ho
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [24] Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes
    Muskiet, Marcel H. A.
    van Bommel, Erik J. M.
    van Raalte, Daniel H.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (03): : 188 - 189
  • [25] Comparison of risk of hyperkalemia between SGLT2 inhibitors and DPP4-inhibitors in patients with type 2 diabetes
    Wu, M. Z.
    Ren, Q. W.
    Huang, J. Y.
    Tse, Y. K.
    Yu, S. Y.
    Cheang, L. F.
    Li, H. L.
    Chan, Y. H.
    Tse, H. F.
    Yiu, K. H.
    EUROPEAN HEART JOURNAL, 2023, 44 : 156 - 156
  • [26] SGLT2 Inhibitors for Type 2 Diabetes
    Liu, Jiwen
    Lee, TaeWeon
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46, 2011, 46 : 103 - +
  • [27] Enhancement of Flattening Glycemic Fluctuation in Patients with Type 2 Diabetes by SGLT2 Inhibitor Combined with DPP-4 Inhibitor
    Cho, Kyuyong
    Nomoto, Hiroshi
    Nakamura, Akinobu
    Omori, Kazuno
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    DIABETES, 2019, 68
  • [28] Treatment for Type-2-Diabetes News: Fixed Combination of DPP-4 and SGLT-2 Inhibitors
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (03): : 157 - 158
  • [29] An update on DPP-4 inhibitors in the management of type 2 diabetes
    Cahn, Avivit
    Cernea, Simona
    Raz, Itamar
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (04) : 409 - 419
  • [30] Could metformin modulate cardiovascular outcomes differently with DPP-4 inhibitors compared with SGLT2 inhibitors?
    Scheen, Andre J.
    DIABETES & METABOLISM, 2021, 47 (04)
12345